Interesting facts
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
This intriguing compound belongs to the class of thiadiazoles, notable for their wide range of biological activities. Here are some interesting insights about N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide:
- Biological Significance: Thiadiazoles have been extensively researched for their potential medicinal properties, including antimicrobial, antifungal, and anti-inflammatory effects. This particular compound may exhibit similar therapeutic potential.
- Sulfamoyl Group: The presence of the sulfamoyl group (-SO2NH2) is significant in many sulfa drugs, which have been used effectively in treating bacterial infections. It's interesting to consider how this group may contribute to the compound's overall biological activity.
- Synthetic Pathways: The synthesis of thiadiazole derivatives often involves multistep chemical reactions. Understanding the synthetic routes can provide insights into the reactivity and stability of various substituents in these compounds.
- Structural Characteristics: The ylidene functional group contributes to the compound's unique reactivity and stability. By examining structural variations, researchers can develop derivatives with enhanced properties.
- Applications in Drug Development: As a potential lead compound, N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide may inspire further modifications that can enhance its therapeutic efficacy against various pathogens or diseases.
In conclusion, this complex compound not only showcases the synergy between different functional groups but also opens up avenues for future research in medicinal chemistry. It serves as a reminder of the intricate relationship between structure and function in organic compounds.
Synonyms
methazolamide
554-57-4
Methenamide
Neptazaneat
Neptazane
Metazolamida
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
Naptazane
CHEBI:6822
Methazolamide, (Z)-
L584601
NSC-758426
Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-
Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-
N-[(2E)-3-Methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide
MLS000028532
DA43GW06P1
VVP808
W733B0S9SD
DTXSID1023281
VVP-808
N-(3-Methyl-5-Sulfamoyl-1,3,4-Thiadiazol-2(3h)-Ylidene)acetamide
NCGC00016508-01
Metazolamide
CAS-554-57-4
SMR000058287
N-(3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene)acetamide
L-584601
Metazolamide [DCIT]
Methazolamidum
(NE)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, (N(Z))-
Metazolamida [INN-Spanish]
Methazolamidum [INN-Latin]
1164547-86-7
HSDB 3269
SR-05000001844
EINECS 209-066-7
BRN 0232387
UNII-W733B0S9SD
2-Acetylimino-3-methyl-.delta.(4)-1,3,4-thiadiazoline-5-sulfonamide
5-Acetylimino-4-methyl-.delta.(2)-1,3,4-thiadiazoline-2-sulfonamide
N-(4-Methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)acetamide
N-(5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide #
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide;
Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)-
(Z)-methazolamide
Neptazane (TN)
Methazolamide,(S)
Methazolamide [USP:INN:BAN:JAN]
Methazolamide, MZA
Prestwick_1007
Methazolamide (MZA)
NoName_433
Spectrum_001615
Opera_ID_717
Methazolamide (Standard)
CHEMBL19
MZA3
Prestwick0_000802
Prestwick1_000802
Prestwick2_000802
Prestwick3_000802
Spectrum2_001543
Spectrum3_001914
Spectrum4_000190
Spectrum5_001006
2-Acetylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide
5-Acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide
METHAZOLAMIDE [MI]
METHAZOLAMIDE [INN]
METHAZOLAMIDE [JAN]
N-(4-Methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)acetamide
cid_4100
METHAZOLAMIDE [HSDB]
UNII-DA43GW06P1
Oprea1_161738
SCHEMBL24686
SCHEMBL24687
BSPBio_000663
BSPBio_003508
KBioGR_000739
KBioSS_002095
METHAZOLAMIDE [VANDF]
4-27-00-08221 (Beilstein Handbook Reference)
MLS001146905
DivK1c_000582
METHAZOLAMIDE [MART.]
SPECTRUM1503252
SPBio_001386
SPBio_002584
METHAZOLAMIDE [USP-RS]
METHAZOLAMIDE [WHO-DD]
BPBio1_000731
CHEMBL288100
DTXCID503281
GTPL6828
Methazolamide (JAN/USP/INN)
US10172837, Methazolamide
SCHEMBL13825893
BDBM10881
CHEBI:94513
HMS501N04
HY-B0553R
KBio1_000582
KBio2_002095
KBio2_004663
KBio2_007231
KBio3_003013
DTXSID50901331
FLOSMHQXBMRNHR-DAXSKMNVSA-N
FLOSMHQXBMRNHR-QPJJXVBHSA-N
Methazolamide, >=98% (HPLC)
NINDS_000582
BDBM315269
GLXC-02995
HMS1570B05
HMS1922M19
HMS2093A05
HMS2097B05
HMS2234L03
HMS3259H05
HMS3372G12
HMS3652E21
HMS3714B05
HMS3747O09
Pharmakon1600-01503252
METHAZOLAMIDE [ORANGE BOOK]
HY-B0553
VWC14230
Tox21_110464
BDBM50013792
CCG-39321
METHAZOLAMIDE [USP MONOGRAPH]
MFCD00083416
NSC758426
AKOS015897587
AKOS024464790
AKOS026749792
CCG-266836
DB00703
KS-5328
NC00618
NSC 758426
SB17307
Acetamide, N-(4-methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)-
IDI1_000582
N-[(2E)-5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
NCGC00016508-03
NCGC00016508-04
NCGC00016508-18
NCGC00018188-01
NCGC00018188-02
NCGC00018188-03
NCGC00018188-04
NCGC00018188-05
NCGC00018188-06
NCGC00018188-07
NCGC00022950-03
NCGC00022950-04
NCGC00178022-01
NCGC00178022-02
AC-32472
AS-13272
SBI-0051804.P002
DB-052736
AB00490015
NS00007349
S4039
SW197085-3
EN300-51717
C07764
D00655
D81966
AB00052336_04
EN300-7412532
A830656
Methazolamide, VETRANAL(TM), analytical standard
Q1149099
SR-05000001844-1
SR-05000001844-2
SR-05000001844-3
BRD-K13356952-001-15-2
BRD-K13356952-001-25-1
BRD-K13356952-001-26-9
BRD-K13356952-001-27-7
BRD-K71053238-001-03-6
BRD-K71053238-001-04-4
Q27276292
Z728800602
(E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide
Methazolamide, United States Pharmacopeia (USP) Reference Standard
(E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide
[N(E)]-N-[5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-, [N(E)]-
N-(4-METHYL-2-SULFAMOYL-.DELTA.(SUP 2)-1,3,4-THIADIAZOLIN-5-YLIDENE)ACETAMIDE
N-[(2Z)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide
2101958-72-7
Solubility of N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide is a chemical compound that presents unique solubility characteristics:
As a rule of thumb in chemistry, “like dissolves like” holds true, indicating that the polar nature of N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide facilitates its solubility in similar polar environments.
In practical applications, understanding the solubility of this compound is essential for its utilization in pharmaceutical formulations and chemical synthesis. Therefore, experimenting under various conditions will yield insights into the solubility profile and optimal usage of this intriguing compound.